药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Bromfenac
Norgestrel
The therapeutic efficacy of Glycochenodeoxycholic Acid can be decreased when used in combination with Norgestrel.
Bromfenac
Norethynodrel
The therapeutic efficacy of Glycochenodeoxycholic Acid can be decreased when used in combination with Norethynodrel.
Bromfenac
Dienogest
The therapeutic efficacy of Glycochenodeoxycholic Acid can be decreased when used in combination with Dienogest.
Bromfenac
Gestodene
The therapeutic efficacy of Glycochenodeoxycholic Acid can be decreased when used in combination with Gestodene.
Bromfenac
Cyproterone acetate
The therapeutic efficacy of Glycochenodeoxycholic Acid can be decreased when used in combination with Cyproterone acetate.
Bromfenac
Drospirenone
The therapeutic efficacy of Glycochenodeoxycholic Acid can be decreased when used in combination with Drospirenone.
Bromfenac
Cholestyramine
Cholestyramine can cause a decrease in the absorption of Glycochenodeoxycholic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bromfenac
Aluminum chloride
Aluminum chloride can cause a decrease in the absorption of Glycochenodeoxycholic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bromfenac
Pralsetinib
Pralsetinib may decrease the excretion rate of Glycochenodeoxycholic Acid which could result in a higher serum level.
Bromfenac
Valinomycin
Glycochenodeoxycholic Acid may decrease the excretion rate of Valinomycin which could result in a higher serum level.
Bromfenac
Letermovir
Glycochenodeoxycholic Acid may decrease the excretion rate of Letermovir which could result in a higher serum level.
Bromfenac
Lenvatinib
Glycochenodeoxycholic Acid may decrease the excretion rate of Lenvatinib which could result in a higher serum level.
Bromfenac
Simeprevir
Glycochenodeoxycholic Acid may decrease the excretion rate of Simeprevir which could result in a higher serum level.
Bromfenac
Fusidic acid
Glycochenodeoxycholic Acid may decrease the excretion rate of Fusidic acid which could result in a higher serum level.
Bromfenac
Cholic Acid
Glycochenodeoxycholic Acid may decrease the excretion rate of Cholic Acid which could result in a higher serum level.
Bromfenac
Relcovaptan
The risk or severity of adverse effects can be increased when Relcovaptan is combined with Glycochenodeoxycholic Acid.
Bromfenac
Buflomedil
The risk or severity of adverse effects can be increased when Buflomedil is combined with Glycochenodeoxycholic Acid.
Bromfenac
Linsidomine
The risk or severity of adverse effects can be increased when Linsidomine is combined with Glycochenodeoxycholic Acid.
Bromfenac
Cloricromen
The risk or severity of adverse effects can be increased when Cloricromen is combined with Glycochenodeoxycholic Acid.
Bromfenac
Picotamide
The risk or severity of adverse effects can be increased when Picotamide is combined with Glycochenodeoxycholic Acid.